Mechanical load-induced alterations in B-type natriuretic peptide gene expression

被引:71
作者
Tokola, H
Hautala, N
Marttila, M
Magga, J
Pikkarainen, S
Kerkelä, R
Vuolteenaho, O
Ruskoaho, H
机构
[1] Univ Oulu, Dept Pharmacol & Toxicol, Bioctr Oulu, Oulu 90014, Finland
[2] Univ Oulu, Dept Physiol, Bioctr Oulu, Oulu 90014, Finland
关键词
gene expression; mechanical load; natriuretic peptides; paracrine factors; transcription factors;
D O I
10.1139/cjpp-79-8-646
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Atrial natriuretic peptide (ANP), B-type natriuretic peptide (BNP), and C-type natriuretic peptide are the known members of the mammalian natriuretic peptide system. Like ANP, BNP is a natriuretic and diuretic hormone that also causes peripheral vasodilation and inhibition of the sympathetic and renin-angiotensin systems. Although originally isolated from porcine brain, the BNP gene is expressed in a specific manner in cardiac myocytes in both the atria and the ventricles, but it is mainly released from the ventricles. The major determinant of BNP secretion is wall stretch, and the levels of BNP mRNA increase substantially in response to cardiac overload. In the clinical setting, BNP appears to be the most powerful neurohumoral predictor of left-ventricular function and prognosis. An acute increase in BNP gene expression occurs within 1 h and mimics the rapid induction of proto-oncogenes in response to hemodynamic stress. BNP can be used as a myocyte-specific marker to identify mechanisms that couple acute mechanical overload to alterations in cardiac gene expression. This paper is focused on the mechanisms that regulate BNP gene expression in cardiac overload. Particularly, autocrine-paracrine factors as well as cytoplasmic signaling pathways and transcription factors involved in mechanical stretch-induced BNP gene expression are discussed.
引用
收藏
页码:646 / 653
页数:8
相关论文
共 64 条
  • [11] A HORMONE-ENCODING GENE IDENTIFIES A PATHWAY FOR CARDIAC BUT NOT SKELETAL-MUSCLE GENE-TRANSCRIPTION
    GREPIN, C
    DAGNINO, L
    ROBITAILLE, L
    HABERSTROH, L
    ANTAKLY, T
    NEMER, M
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1994, 14 (05) : 3115 - 3129
  • [12] RAPID VENTRICULAR INDUCTION OF BRAIN NATRIURETIC PEPTIDE GENE-EXPRESSION IN EXPERIMENTAL ACUTE MYOCARDIAL-INFARCTION
    HAMA, N
    ITOH, H
    SHIRAKAMI, G
    NAKAGAWA, O
    SUGA, S
    OGAWA, Y
    MASUDA, I
    NAKANISHI, K
    YOSHIMASA, T
    HASHIMOTO, Y
    YAMAGUCHI, M
    HORI, R
    YASUE, H
    NAKAO, K
    [J]. CIRCULATION, 1995, 92 (06) : 1558 - 1564
  • [13] HANFORD DS, 1994, J BIOL CHEM, V269, P26227
  • [14] Stabilization of the B-type natriuretic peptide mRNA in cardiac myocytes by alpha-adrenergic receptor activation: Potential roles for protein kinase C and mitogen-activated protein kinase
    Hanford, DS
    Glembotski, CC
    [J]. MOLECULAR ENDOCRINOLOGY, 1996, 10 (12) : 1719 - 1727
  • [15] Pressure overload induces cardiac hypertrophy in angiotensin II type 1A receptor knockout mice
    Harada, K
    Komuro, I
    Shiojima, I
    Hayashi, D
    Kudoh, S
    Mizuno, T
    Kijima, K
    Matsubara, H
    Sugaya, T
    Murakami, K
    Yazaki, Y
    [J]. CIRCULATION, 1998, 97 (19) : 1952 - 1959
  • [16] Interaction of myocytes and nonmyocytes is necessary for mechanical stretch to induce ANP/BNP production in cardiocyte culture
    Harada, M
    Saito, Y
    Kuwahara, K
    Ogawa, E
    Ishikawa, M
    Nakagawa, O
    Miyamoto, Y
    Kamitani, S
    Hamanaka, I
    Kajiyama, N
    Takahashi, N
    Masuda, I
    Itoh, H
    Nakao, K
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1998, 31 : S357 - S359
  • [17] Hasegawa K, 1997, CIRCULATION, V96, P3943
  • [18] Hautala N, 2001, CIRCULATION, V103, P730
  • [19] Angiotensin II type(1a) receptor gene expression in the heart: AP-1 and GATA-4 participate in the response to pressure overload
    Herzig, TC
    Jobe, SM
    Aoki, H
    Molkentin, JD
    Cowley, AW
    Izumo, S
    Markham, BE
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (14) : 7543 - 7548
  • [20] Endothelin-1 is involved in norepinephrine-induced ventricular hypertrophy in vivo acute effects of Bosentan, an orally active, mixed endothelin ET(A) and ET(B) receptor antagonist
    Kaddoura, S
    Firth, JD
    Boheler, KR
    Sugden, PH
    PooleWilson, PA
    [J]. CIRCULATION, 1996, 93 (11) : 2068 - 2079